Authors: Heppeler, A Froidevaux, S Eberle, AN Maecke, HR

Citation: A. Heppeler et al., Receptor targeting for tumor localisation and therapy with radiopeptides, CURR MED CH, 7(9), 2000, pp. 971-994

Authors: Reubi, JC Schar, JC Waser, B Wenger, S Heppeler, A Schmitt, JS Macke, HR

Citation: Jc. Reubi et al., Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use, EUR J NUCL, 27(3), 2000, pp. 273-282

Authors: Froidevaux, S Heppeler, A Eberle, AN Meier, AM Hausler, M Beglinger, C Behe, M Powell, P Macke, HR

Citation: S. Froidevaux et al., Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy, ENDOCRINOL, 141(9), 2000, pp. 3304-3312

Authors: Heppeler, A Froidevaux, S Macke, HR Jermann, E Behe, M Powell, P Hennig, M

Citation: A. Heppeler et al., Radiometal-labelled macrocyclic chelator-derivatised somatostatin analoguewith superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy, CHEM-EUR J, 5(7), 1999, pp. 1974-1981

Authors: Otte, A Herrmann, R Heppeler, A Behe, M Jermann, E Powell, P Maecke, HR Muller, J

Citation: A. Otte et al., Yttrium-90 DOTATOC: first clinical results, EUR J NUCL, 26(11), 1999, pp. 1439-1447